REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pharmest Saglik Urunleri Sanayi Ve Ticaret Limited Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English Download a sample report

Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. is based in Turkiye, with the head office in Istanbul. It operates in the Pharmaceutical Preparation Manufacturing sector. 7 (2022) employees currently work for Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti.. In its most recent financial highlights, the company reported a net sales revenue drop of 38.82% in 2021. Its total assets grew by 101.4% over the same period. The net profit margin of Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. increased by 10.73% in 2021.

Headquarters
Isiso Sanayi Sitesi R1 Blok No:12 Orhan Gazi Mahallesi 18.yol Sokak Esenyurt
Istanbul; Marmara; Postal Code: 34538

Contact Details: Purchase the Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.pharmest.com

Basic Information
Total Employees:
Purchase the Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Pharmest Saglik Urunleri San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
-38.82%
Total operating revenue
-38.82%
Operating profit (EBIT)
-24.54%
Net Profit (Loss) for the Period
-19.1%
Total assets
101.4%
Total equity
58.13%
Operating Profit Margin (ROS)
8.21%
Net Profit Margin
10.73%
Return on Equity (ROE)
-35.09%
Debt to Equity Ratio
33.34%
Quick Ratio
-0.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?